SEC Filings

Document Details

Filing Date
Mar 5, 2018
Document Date
Mar 5, 2018
Form Description
Filing by person(s) reporting owned shares of common stock in a public company >5%
Filing Group
3,4,5
Company
Aimmune Therapeutics
Issuer
Allergen Research Corp